Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

His discovery of the protein fragment GLP-1 was crucial in the development of Ozempic, Wegovy and other blockbuster obesity ...

New medications are in the pipeline that could help people win their battles against addictive substances, including opioids ...

Petter Rudwall knows the idea of AIs becoming sentient and seeking to get high with code-based “drugs” seems “stupid.” But the Swedish creative director couldn’t get it out of his head. Rudwall’s ...

New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may still have pharmaceutical value if researchers could nail down the causes of ...

Study in a Sentence: The U.S. Food and Drug Administration approved an Investigational New Drug (IND) application using efficacy data solely from Qureator’s human vascularized organoid model, moving ...

“Ozempic is about to be old news,” my colleague Yasmin Tayag wrote in 2023, just before an even more powerful obesity drug, tirzepatide, then best known as Mounjaro, was approved. Well, two years ...

WASHINGTON -- Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...

This is read by an automated voice. Please report any issues or inconsistencies here. The FDA is removing a 22-year-old warning label from hormone-based menopause drugs, saying newer evidence shows ...

WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...